Fondaparinux overdosage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Fondaparinux overdosage": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Fondaparinux#Overdosage]]
{{Fondaparinux}}
{{CMG}}; {{AE}} {{AZ}}


==Overdosage==
[[Category: Cardiovascular Drugs]]
*There is no known antidote for ARIXTRA. Overdose of ARIXTRA may lead to hemorrhagic complications.
[[Category: Drug]]
*'''Discontinue treatment and initiate appropriate therapy if bleeding complications associated with overdosage occur'''.
[[Category: Anticoagulants]]
*Data obtained in patients undergoing chronic intermittent hemodialysis suggest that clearance of ARIXTRA can increase by 20% during [[hemodialysis]].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARIXTRA (FONDAPARINUX SODIUM) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=05bb2dd4-5fb5-4ec9-29a8-d200e62d1a8f | publisher =  | date =  | accessdate =  }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Latest revision as of 21:14, 18 August 2015

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Fondaparinux_overdosage&oldid=1135416"